Target intelligence / Profile preview

Firmicutes to Bacteroidetes ratio (F/B ratio)

Target
F/B ratio
Molecular classification
Other (microbiome composition metric; not a molecule, not a protein, not a receptor)
01

Overview

Firmicutes/Bacteroidetes ratio refers to the quotient of the relative abundances of Firmicutes (a phylum of Gram-positive bacteria) and Bacteroidetes (a phylum of Gram-negative bacteria) in the human gut microbiome. This ratio is widely studied as a broad marker of gut health and dysbiosis, with particular links to obesity—a higher ratio is often observed in obese individuals, while a lower ratio is associated with inflammatory bowel disease. The ratio is not a molecular drug target but rather a descriptive parameter measured via sequencing of stool samples. It is subject to considerable biological and methodological variability, and while it offers a simple overview of microbiome composition, its utility as a clinically reliable biomarker remains debated and context-dependent[1][3][7]. For structured data extraction, this entry should be flagged as a metric/biomarker, not a molecule or classical drug target.

Other names
F/B ratioFirmicutes:Bacteroidetes ratioFirmicutes-to-Bacteroidetes ratio
02

Mechanism of action

Altering microbiota composition to restore balance (e.g., probiotics increase Bacteroidetes or decrease Firmicutes depending on species) Modulation of fermentation and SCFA production via dietary interventions (fiber increases Bacteroidetes) Immunomodulation via induced changes in microbiome composition

03

Biological functions

Marker of gut microbial compositionIndicator of intestinal homeostasis and dysbiosisAssociated with energy extraction from food and short-chain fatty acid (SCFA) production by microbiota
04

Disease associations

Obesity: Higher F/B ratio suggested as a marker for obesityMetabolic disorders: Linked to type 2 diabetes and metabolic syndromeCardiovascular diseaseInflammatory bowel disease: Lower ratio observed in IBDOther: Breast cancer, benign prostatic hyperplasia, gestational diabetes, possible links to broader inflammatory or gastrointestinal disease
05

Safety considerations

Not amenable to direct targeting (cannot be modulated as a druggable protein)Large biological variability between individuals and populations, influenced by diet, age, environment, medications, and geneticsMethodological inconsistency between studies: variable sequencing platforms, sampling protocols, and analysis methods yield conflicting resultsUse in patient management is controversial; not a universally reliable markerAdjustment of the ratio carries unknown risks; overcorrection or indiscriminate microbiome modification may have unintended effects
06

Interacting drugs

Probiotics (primarily Lactobacillus, etc.)

2 more in the full profile.

07

Biomarkers

Firmicutes/Bacteroidetes ratio itself is used as a biomarker of dysbiosis, obesity risk, metabolic syndrome, and inflammatory disordersSpecific species or SCFA levels (not the ratio directly)

Beyond the preview

Go deeper on Firmicutes to Bacteroidetes ratio (F/B ratio).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Firmicutes to Bacteroidetes ratio (F/B ratio).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call